Latest News & Updates

Breaking News

  • 14 hours ago

  • Simantini Singh Deo

Automated Cell Therapy Manufacturing Secures $1.1 Billion Across 34 Funding Rounds Led by Cellares and Ori Biotech
Breaking News
Alembic Pharma Gains USFDA Tentative Approval for Binimetinib Tablets as Sole First Applicant

Simantini Singh Deo

Other trending news you may like to read

Automated Cell Therapy Manufacturing Secures $1.1 Billion Across 34 Funding Rounds Led by Cellares and Ori Biotech

A $1.1B funding wave across 34 rounds is consolidating automated cell therapy GMP platforms around Cellares and Ori Biotech.

Simantini Singh Deo

Pharma Now

Alembic Pharma Gains USFDA Tentative Approval for Binimetinib Tablets as Sole First Applicant

Alembic Pharma gains USFDA tentative approval for Binimetinib 45 mg as sole first applicant, opening a potential 180-day generic exclusivity window.

Simantini Singh Deo

Pharma Now

Zydus Acquires Assertio in Deal Targeting US Specialty Pharma Portfolio Expansion

Zydus Lifesciences acquires Assertio, making it a wholly owned subsidiary and expanding its US specialty pharma footprint under direct FDA oversight.

Simantini Singh Deo

Pharma Now

Sanofi Gains Japan Approval for Sarclisa Subcutaneous Formulation in Multiple Myeloma

Sanofi's Sarclisa SC gains Japan approval for multiple myeloma; CirCLIQ on-body injector application remains under review.

Vaibhavi M.

Pharma Now